title: Reversible vigabatrin-induced life-threatening encephalopathy.
authors.affiliation: Department of Paediatric Neurosciences, Evelina Children's Hospital, St Thomas' Hospital, King's Health Partners Academic Health Science Centre, London, England.
authors.forename: Yaiza
authors.initials: Y
authors.lastname: Hernández Vega
authors.affiliation: Department of Paediatric Neurosciences, Evelina Children's Hospital, St Thomas' Hospital, King's Health Partners Academic Health Science Centre, London, England.
authors.forename: Marios
authors.initials: M
authors.lastname: Kaliakatsos
authors.affiliation: Department of Neuroradiology, Kings College Hospital, King's Health Partners Academic Health Science Centre, London, England.
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: U-King-Im
authors.affiliation: Department of Paediatric Neurosciences, Evelina Children's Hospital, St Thomas' Hospital, King's Health Partners Academic Health Science Centre, London, England.
authors.forename: Karine
authors.initials: K
authors.lastname: Lascelles
authors.affiliation: Department of Paediatric Neurosciences, Evelina Children's Hospital, St Thomas' Hospital, King's Health Partners Academic Health Science Centre, London, England.
authors.forename: Ming
authors.initials: M
authors.lastname: Lim
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects*; D001921:Brain / Q000187:drug effects*; D001927:Brain Diseases / Q000139:chemically induced* / Q000401:mortality; D005260:Female; D006801:Humans; D007223:Infant; D008279:Magnetic Resonance Imaging / Q000379:methods*; D013036:Spasms, Infantile / Q000188:drug therapy; D020888:Vigabatrin / Q000009:adverse effects*
chemical_list: D000927:Anticonvulsants; D020888:Vigabatrin